(1) Clinical and Experimental Pharmacology, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK;(2) School of Cancer and Enabling Sciences, University of Manchester, Manchester, UK
Abstract:
Objective
To observe the reversion of multi-drug resistance by proteasome inhibitor bortezomib in K562/DNR cell line and to analyze the possible mechanism of reversion of multidrug-resistance.